| Dr Ryan Allen Sarsfield, MD | |
|
238 Summar Dr, Jackson, TN 38301-3906 | |
| (731) 541-8200 | |
| (731) 541-8327 |
| Full Name | Dr Ryan Allen Sarsfield |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 238 Summar Dr, Jackson, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508351669 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 125.073351 (Illinois) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 66491 (Tennessee) | Primary |
| Entity Name | Pathways Of Tennessee Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497721609 PECOS PAC ID: 6507833613 Enrollment ID: O20040916000523 |
News Archive
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) has announced that its clinical trial application (CTA) for ANAVEX 2-73, the company's lead compound for Alzheimer's disease, has been approved by the German regulatory health authority, BfArM. The Phase I trial of ANAVEX 2-73, which includes testing in healthy human volunteers, will commence immediately. In this Phase I program Anavex will assess the safety, maximally tolerated dose, pharmacokinetics and pharmacodynamics of ANAVEX 2-73.
America's Health Insurance Plans and the American Medical Association launch new television ads on health care.
As part of its ongoing commitment to providing patient-centered care, NYU Langone Medical Center has created a state-of-the-art pharmacy to maximize efficiency and enhance patient safety. Made possible as part of a generous gift from the Tisch families, the new pharmacy features advanced robotic equipment that automatically sorts and dispenses medications with 99.99% accuracy. Located on the 3rd floor of the Medical Center's flagship Tisch Hospital, the new pharmacy is the first of its kind in New York City and the second in New York State.
Novel treatments that harness the body's own immune cells to attack cancer cells demonstrate safe and durable responses in patients with relapsed and treatment-resistant blood cancers, according to data presented today at the 56th American Society of Hematology Annual Meeting and Exposition.
Survival outcomes and overall complication rates of partial nephrectomy for clinical T2 renal masses are comparable to those of radical nephrectomy when the pathological staging, histology and grading of the tumours are similar, researchers report.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan Allen Sarsfield, MD 238 Summar Dr, Jackson, TN 38301-3906 Ph: (731) 541-8200 | Dr Ryan Allen Sarsfield, MD 238 Summar Dr, Jackson, TN 38301-3906 Ph: (731) 541-8200 |
News Archive
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) has announced that its clinical trial application (CTA) for ANAVEX 2-73, the company's lead compound for Alzheimer's disease, has been approved by the German regulatory health authority, BfArM. The Phase I trial of ANAVEX 2-73, which includes testing in healthy human volunteers, will commence immediately. In this Phase I program Anavex will assess the safety, maximally tolerated dose, pharmacokinetics and pharmacodynamics of ANAVEX 2-73.
America's Health Insurance Plans and the American Medical Association launch new television ads on health care.
As part of its ongoing commitment to providing patient-centered care, NYU Langone Medical Center has created a state-of-the-art pharmacy to maximize efficiency and enhance patient safety. Made possible as part of a generous gift from the Tisch families, the new pharmacy features advanced robotic equipment that automatically sorts and dispenses medications with 99.99% accuracy. Located on the 3rd floor of the Medical Center's flagship Tisch Hospital, the new pharmacy is the first of its kind in New York City and the second in New York State.
Novel treatments that harness the body's own immune cells to attack cancer cells demonstrate safe and durable responses in patients with relapsed and treatment-resistant blood cancers, according to data presented today at the 56th American Society of Hematology Annual Meeting and Exposition.
Survival outcomes and overall complication rates of partial nephrectomy for clinical T2 renal masses are comparable to those of radical nephrectomy when the pathological staging, histology and grading of the tumours are similar, researchers report.
› Verified 8 days ago
Dr. Michael W Brueggeman, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 West Forest, Ste 200, Jackson, TN 38301 Phone: 731-541-9490 Fax: 731-541-9485 | |
Elias K Bond, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 616 W Forest Ave, Jackson, TN 38301 Phone: 731-422-0348 | |
David Scott Helm, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2863 Highway 45 Byp, Jackson, TN 38305 Phone: 731-422-0348 Fax: 731-422-0240 | |
Dr. William Charles Barrow, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 700 W Forest Ave, Ste 200, Jackson, TN 38301 Phone: 731-541-9490 | |
Vadankumar Manibhai Patel, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 238 Summar Dr, Jackson, TN 38301 Phone: 731-935-8200 Fax: 731-935-8327 | |
Catherine M Greene, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 45 Executive Dr, Jackson, TN 38305 Phone: 731-664-2083 Fax: 731-664-1988 |